FDA Program Promises to End Years of Ketamine Shortages for Mental Health Clinics
Phlow Corp. has been selected for the FDA's inaugural Commissioner's National Priority Voucher Pilot Program to manufacture ketamine's active pharmaceutical
Read More
Phlow Corp. has been selected for the FDA's inaugural Commissioner's National Priority Voucher Pilot Program to manufacture ketamine's active pharmaceutical
Read More
Early studies show how psychedelic drugs impact mental health issues.
Read More
Research shows how psilocybin therapy is impacting mental health issues in a positive way.
Read More
We explain what a psychedelic therapy container is, and why it's critical while using psychedelics as medicine.
Read More
We're one step closer. Mindmed just dosed their first patient in their clinical trial using LSD to treat anxiety.
Read More
Among more than 650 participants, many reported a reduction in headache symptoms following their experience.
Read More
More than 49,000 Americans died by suicide in 2022, representing a 3% jump over the previous year and the highest
Read More
Federal officials are signaling growing momentum behind psychedelic drug development. The flood of applications reflects broad enthusiasm.
Read More
Studies suggest Ayahuasca tea could improve everyday mental health struggles.
Read More
Can psychedelics help relieve brain damage from alcohol? Research appears to support it.
Read More